Spironolactone inhibits production of proinflammatory cytokines by human mononuclear cells
Research output: Contribution to journal › Journal article › Research › peer-review
The mineralocorticoid receptor antagonist spironolactone (SPIR) reduces the mortality and morbidity in patients with congestive heart failure (CHF). Overexpression of proinflammatory cytokines contribute to the development and progression of CHF.
| Original language | English |
|---|---|
| Journal | Immunology Letters |
| Volume | 91 |
| Issue number | 2-3 |
| Pages (from-to) | 87-91 |
| Number of pages | 5 |
| ISSN | 0165-2478 |
| DOIs | |
| Publication status | Published - 15 Feb 2004 |
ID: 34077034